Skip NavigationSkip to Content

JS-K, a nitric oxide prodrug, induces cytochrome c release and caspase activation in HL-60 myeloid leukemia cells

  1. Author:
    Udupi, V.
    Yu, M.
    Malaviya, S.
    Saavedra, J. E.
    Shami, P. J.
  2. Author Address

    Univ Utah, Salt Lake City, UT 84112 USA. SAIC, Frederick, MD USA.;Shami, PJ, Huntsman Canc Inst, Suite 2100,2000 Circle Hope, Salt Lake City, UT 84112 USA.;p.shami@m.cc.utah.edu
    1. Year: 2006
    2. Date: Oct
  1. Journal: Leukemia Research
    1. 30
    2. 10
    3. Pages: 1279-1283
  2. Type of Article: Article
  3. ISSN: 0145-2126
  1. Abstract:

    Nitric oxide (NO) induces differentiation and apoptosis in acute myelogenous leukemia (AML) cells. The NO prodrug O-2-(2,4-dinitrophenyl)l-[(4-ethoxycarbonyl)piperazin-l-yl]diazen-l-ium- 1,2-diolate, or JS-K, has potent antileukemic activity. JS-K induces apoptosis in HL-60 cells by a caspase-dependent mechanism. The purpose of this study was to determine the pathway through which JS-K induces apoptosis. We show that JS-K alters mitochondrial membrane potential (Delta psi(m)) and induces cytochrome c release from mitochondria into the cytoplasm. Treatment with JS-K resulted in activation of Caspase (Casp) 9, Casp 3 and Casp 8. JS-K constitutes a promising lead for a new class of anti-leukemic agents. (c) 2005 Elsevier Ltd. All rights reserved.

    See More

External Sources

  1. DOI: 10.1016/j.leukres.2005.12.007
  2. WOS: 000240816600012

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel